isirv

Adam Meijer
National Institute for Public Health, Bilthoven, The Netherlands

Adam Meijer graduated in 1999 at the Faculty of Medicine of the University of Utrecht, the Netherlands, on the thesis: Chlamydia pneumoniae infection and atherosclerosis, a molecular analysis. Since 2001 he has worked in the field of influenza. During 2001 he studied the effect of antiviral prophylaxis and treatment on transmission of avian influenza between chickens at the Central Institute for Animal Disease Control, Lelystad, the Netherlands. In 2002 he continued his work on influenza at the National Institute of Public Health and the Environment, Bilthoven, the Netherlands and since 2003 has headed the Section Respiratory Viruses of the Virology department of the Laboratory for Infectious Diseases.

Dr Meijer’s research focuses on virological surveillance of acute respiratory infections, with a special focus on antiviral susceptibility and determination of molecular determinants for virulence and transmission networks at the animal-human interface. From 2003-2008 he coordinated the virology activities of the European Influenza Surveillance Scheme (EISS) and was instrumental in the establishment and coordination of the Community Network of Reference Laboratories for Human Influenza in Europe (CNRL). Since 2008 he is one of the coordinators of the CNRL under the auspices of the European Centre of Disease Control and Prevention, with a special focus on influenza antivirals. He is advisor for the influenza external quality assessment programme of QCMD, Glasgow, Scotland, has been involved in several influenza consultation meetings of the WHO (e.g. on rapid tests for influenza and on susceptibility of influenza viruses for antivirals) and recently joined the WHO GISRS working group on antiviral susceptibility.